Lorraine Mullaney, Author at CannIntelligence | Page 4 of 4

Charity invests in CBD trials for Parkinson’s symptom relief

Written by Lorraine Mullaney || 14th January 2020 || News analysis |

As more victims of Parkinson’s disease turn to CBD to relieve symptoms such as tremors, anxiety and insomnia, Parkinson’s UK is investing in a clinical trial into how CBD might benefit those suffering Parkinson’s-related psychosis ...

‘Potential goes beyond CBD and THC – but consumers need educating’

Written by Lorraine Mullaney || 12th November 2019 || News analysis |

Educating consumers is the key to success in the fast-moving industry of cannabis-based products, says Melissa Jochim, founder of High Beauty, a brand of skincare products from pressed hemp seed oil ...

Full-spectrum products are ‘the future’, says pro-hemp vet

Written by Lorraine Mullaney || 29th October 2019 || News analysis |

California vet Tim Shu, founder of Vet CBD and Dr Shu’s Pet Care, discusses the future of full-spectrum products, cannabinoid therapeutics, and the need for further research and regulation ...

Into the fourth dimension, and other stories: CBD business news in brief

Written by Lorraine Mullaney || 28th October 2019 || News analysis |

A bumper crop of business briefs includes news of a “unique 4D, shape-changing cannabinoid and active ingredient delivery system” ...

US health organisations respond to rise of CBD with cautious optimism

Written by Lorraine Mullaney || 17th October 2019 || News analysis |

Medical associations in the US say they are optimistic about the potential for CBD to treat patients, but have warned people to proceed with caution when treating themselves due to a lack of rigorous scientific studies ...

US universities take positive steps for hemp research and innovation

Written by Lorraine Mullaney || 15th October 2019 || News analysis |

Funding success for new developments in hemp research, as well as innovations such as monitoring the path of pollen using drones ...

Lung outbreak: CDC, FDA now focused on THC, but public more worried by nicotine

Written by Lorraine Mullaney || 4th October 2019 || News analysis |

The American public believes nicotine e-cigarettes to be more dangerous than THC vaping, even as official statements on the recent outbreak of lung disease start to emphasise the role of cannabis and play down the involvement of nicotine...

Good evidence – and the lack of it: CBD-Intel science news in brief

Written by Lorraine Mullaney || 25th September 2019 || News analysis |

Scientific studies reveal varying views on the use of CBD and cannabis in treating PTSD, HIV, depression, anxiety and stress, while parents are warned not to give CBD to their children ...

US consumer study finds CBD levels matter most to medical cannabis users

Written by Lorraine Mullaney || 22nd August 2019 || News analysis |

Consumers looking for the medical benefits of cannabis are willing to pay a premium for high-CBD flowers, according to the findings of a new study by a group of US universities ...

New clinical trial investigates CBD-infused oral health products

Written by Lorraine Mullaney || 19th August 2019 || News analysis |

A new clinical trial is investigating the efficacy of CBD-infused mouthwashes and toothpaste when used to treat gum disease. The randomised controlled clinical trial is a collaboration between Australian medicinal cannabis business Impression Healthcare and US-based pharmaceutical-grade medical...

A hole in one – will sports and CBD continue to entwine?

Written by Lorraine Mullaney || 8th August 2019 || News analysis |

The sports world is becoming increasingly enamoured with CBD. US professional golfers have become the latest sporting personalities to endorse CBD products, including 2009 US Open winner Lucas Glover. Will CBD continue to wind its way into the professional...

Getting the dosage right is crucial to CBD’s mainstream future, says expert

Written by Lorraine Mullaney || 3rd July 2019 || Market reports |

Accurate and consistent CBD dosage will be vital for the industry as edible items become the biggest category of cannabinoid-derived products, experts predict ...

CBD is a feminist issue too as women take a progressive leading role

Written by Lorraine Mullaney || 1st May 2019 || News analysis |

Women are emerging as key players in the movement to promote medical CBD: starting their own businesses, campaigning for legalisation and creating networks for future empowerment ...

LATEST ALERTS